...
首页> 外文期刊>Journal of refractive surgery >Corneal collagen cross-linking for Terrien marginal degeneration
【24h】

Corneal collagen cross-linking for Terrien marginal degeneration

机译:角膜胶原交联用于Terrien边缘变性

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: To report the long-term clinical outcome of a patient diagnosed as having Terrien marginal degeneration (TMD) who was subjected to corneal collagen cross-linking (CXL) with ultraviolet-A and riboflavin in both eyes. METHODS: Topographical changes were assessed by high-resolution Scheimpflug imaging and anterior segment optical coherence tomography. Eccentric epithelium-off CXL was performed in both eyes while protecting the corneal limbus. Irradiation was performed with a fluence of 5.4 J/cm2, using 3 mW/cm2 for 30 minutes. RESULTS: Five years of postoperative follow-up showed regression of the keratometric values, a local thickening of the corneal stroma, and bilateral improvement of corrected distance visual acuity. CONCLUSIONS: CXL may arrest progression in TMD and even reverse the catabolic process in the corneal stroma. CXL might represent an alternative therapeutic approach for the management of TMD.
机译:目的:报告诊断为患有Terrien边缘变性(TMD)的患者的长期临床结果,该患者在两只眼睛中均接受了紫外线A和核黄素的角膜胶原交联(CXL)。方法:通过高分辨率Scheimpflug成像和前节光学相干断层扫描评估地形变化。在保护角膜缘的同时在两只眼睛中进行了偏心上皮脱落CXL。以5.4J / cm 2的通量进行辐照,使用3mW / cm 2辐照30分钟。结果:术后五年的随访显示,角膜曲率值降低,角膜基质局部增厚,双眼矫正远视力得到改善。结论:CXL可能阻止TMD的进展,甚至逆转角膜基质的分解代谢过程。 CXL可能代表TMD管理的替代治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号